BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18535105)

  • 1. Effect of des-acyl ghrelin on adiposity and glucose metabolism.
    Zhang W; Chai B; Li JY; Wang H; Mulholland MW
    Endocrinology; 2008 Sep; 149(9):4710-6. PubMed ID: 18535105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High level overexpression of glucose transporter-4 driven by an adipose-specific promoter is maintained in transgenic mice on a high fat diet, but does not prevent impaired glucose tolerance.
    Gnudi L; Tozzo E; Shepherd PR; Bliss JL; Kahn BB
    Endocrinology; 1995 Mar; 136(3):995-1002. PubMed ID: 7867610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of Ghrelin Exacerbates HFCS-Induced Adiposity and Insulin Resistance.
    Ma X; Lin L; Yue J; Wu CS; Guo CA; Wang R; Yu KJ; Devaraj S; Murano P; Chen Z; Sun Y
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28629187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of ghrelin transgenic mice for elucidation of clinical implication of ghrelin.
    Aotani D; Ariyasu H; Shimazu-Kuwahara S; Shimizu Y; Nomura H; Murofushi Y; Kaneko K; Izumi R; Matsubara M; Kanda H; Noguchi M; Tanaka T; Kusakabe T; Miyazawa T; Nakao K
    Endocr J; 2017; 64(Suppl.):S31-S33. PubMed ID: 28652541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis.
    Delhanty PJ; Huisman M; Baldeon-Rojas LY; van den Berge I; Grefhorst A; Abribat T; Leenen PJ; Themmen AP; van der Lely AJ
    FASEB J; 2013 Apr; 27(4):1690-700. PubMed ID: 23299855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. aP2-Cre Mediated Ablation of GHS-R Attenuates Adiposity and Improves Insulin Sensitivity during Aging.
    Lin L; Lee JH; Wang R; Wang R; Sheikh-Hamad D; Zang QS; Sun Y
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30275401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FABP4-Cre Mediated Expression of Constitutively Active ChREBP Protects Against Obesity, Fatty Liver, and Insulin Resistance.
    Nuotio-Antar AM; Poungvarin N; Li M; Schupp M; Mohammad M; Gerard S; Zou F; Chan L
    Endocrinology; 2015 Nov; 156(11):4020-32. PubMed ID: 26248218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonism of ghrelin receptor reduces food intake and body weight gain in mice.
    Asakawa A; Inui A; Kaga T; Katsuura G; Fujimiya M; Fujino MA; Kasuga M
    Gut; 2003 Jul; 52(7):947-52. PubMed ID: 12801949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted intestinal overexpression of the immediate early gene tis7 in transgenic mice increases triglyceride absorption and adiposity.
    Wang Y; Iordanov H; Swietlicki EA; Wang L; Fritsch C; Coleman T; Semenkovich CF; Levin MS; Rubin DC
    J Biol Chem; 2005 Oct; 280(41):34764-75. PubMed ID: 16085642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wnt10b inhibits development of white and brown adipose tissues.
    Longo KA; Wright WS; Kang S; Gerin I; Chiang SH; Lucas PC; Opp MR; MacDougald OA
    J Biol Chem; 2004 Aug; 279(34):35503-9. PubMed ID: 15190075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone receptor antagonist transgenic mice are protected from hyperinsulinemia and glucose intolerance despite obesity when placed on a HF diet.
    Yang T; Householder LA; Lubbers ER; List EO; Troike K; Vesel C; Duran-Ortiz S; Kopchick JJ; Berryman DE
    Endocrinology; 2015 Feb; 156(2):555-64. PubMed ID: 25406017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AP2-NR4A3 transgenic mice display reduced serum epinephrine because of increased catecholamine catabolism in adipose tissue.
    Walton RG; Zhu X; Tian L; Heywood EB; Liu J; Hill HS; Liu J; Bruemmer D; Yang Q; Fu Y; Garvey WT
    Am J Physiol Endocrinol Metab; 2016 Jul; 311(1):E69-81. PubMed ID: 27166283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fabp4-Cre-mediated
    Xiong X; Zhang C; Zhang Y; Fan R; Qian X; Dong XC
    J Endocrinol; 2017 Jun; 233(3):307-314. PubMed ID: 28385723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation of obesity and impaired glucose disposal in mice overexpressing acyl coenzyme a:diacylglycerol acyltransferase 1 in white adipose tissue.
    Chen HC; Stone SJ; Zhou P; Buhman KK; Farese RV
    Diabetes; 2002 Nov; 51(11):3189-95. PubMed ID: 12401709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-Biased Physiological Roles of NPFF1R, the Canonical Receptor of RFRP-3, in Food Intake and Metabolic Homeostasis Revealed by its Congenital Ablation in mice.
    Leon S; Velasco I; Vázquez MJ; Barroso A; Beiroa D; Heras V; Ruiz-Pino F; Manfredi-Lozano M; Romero-Ruiz A; Sanchez-Garrido MA; Dieguez C; Pinilla L; Roa J; Nogueiras R; Tena-Sempere M
    Metabolism; 2018 Oct; 87():87-97. PubMed ID: 30075164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice with chronically increased circulating ghrelin develop age-related glucose intolerance.
    Reed JA; Benoit SC; Pfluger PT; Tschöp MH; D'Alessio DA; Seeley RJ
    Am J Physiol Endocrinol Metab; 2008 Apr; 294(4):E752-60. PubMed ID: 18270302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of monocyte chemoattractant protein-1 in adipose tissues causes macrophage recruitment and insulin resistance.
    Kamei N; Tobe K; Suzuki R; Ohsugi M; Watanabe T; Kubota N; Ohtsuka-Kowatari N; Kumagai K; Sakamoto K; Kobayashi M; Yamauchi T; Ueki K; Oishi Y; Nishimura S; Manabe I; Hashimoto H; Ohnishi Y; Ogata H; Tokuyama K; Tsunoda M; Ide T; Murakami K; Nagai R; Kadowaki T
    J Biol Chem; 2006 Sep; 281(36):26602-14. PubMed ID: 16809344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of transgenic mice overexpressing a ghrelin analog.
    Yamada G; Ariyasu H; Iwakura H; Hosoda H; Akamizu T; Nakao K; Kangawa K
    Endocrinology; 2010 Dec; 151(12):5935-40. PubMed ID: 20962048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMGA1 overexpression in adipose tissue impairs adipogenesis and prevents diet-induced obesity and insulin resistance.
    Arce-Cerezo A; García M; Rodríguez-Nuevo A; Crosa-Bonell M; Enguix N; Peró A; Muñoz S; Roca C; Ramos D; Franckhauser S; Elias I; Ferre T; Pujol A; Ruberte J; Villena JA; Bosch F; Riu E
    Sci Rep; 2015 Sep; 5():14487. PubMed ID: 26411793
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose transporter isoform-3-null heterozygous mutation causes sexually dimorphic adiposity with insulin resistance.
    Ganguly A; Devaskar SU
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1144-51. PubMed ID: 18445753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.